基因组不稳定性
生物
DNA损伤
DNA修复
雷达51
癌变
癌症研究
支票1
乳腺癌
细胞周期蛋白D
DNA复制
细胞周期
细胞周期蛋白E1
分子生物学
细胞生物学
癌症
细胞周期蛋白
细胞周期检查点
遗传学
DNA
作者
Mi Li,Spiridon Tsavachidis,Fuchenchu Wang,Tuyen N. Bui,Tuyen Duong Thanh Nguyen,Linjie Luo,Asha S. Multani,Melissa L. Bondy,Kelly K. Hunt,Khandan Keyomarsi
出处
期刊:Oncogene
[Springer Nature]
日期:2022-11-07
卷期号:41 (50): 5331-5346
被引量:16
标识
DOI:10.1038/s41388-022-02527-z
摘要
Low-molecular-weight cyclin E (LMW-E) is an N-terminus deleted (40 amino acid) form of cyclin E detected in breast cancer, but not in normal cells or tissues. LMW-E overexpression predicts poor survival in breast cancer patients independent of tumor proliferation rate, but the oncogenic mechanism of LMW-E and its unique function(s) independent of full-length cyclin E (FL-cycE) remain unclear. In the current study, we found LMW-E was associated with genomic instability in early-stage breast tumors (n = 725) and promoted genomic instability in human mammary epithelial cells (hMECs). Mechanistically, FL-cycE overexpression inhibited the proliferation of hMECs by replication stress and DNA damage accumulation, but LMW-E facilitated replication stress tolerance by upregulating DNA replication and damage repair. Specifically, LMW-E interacted with chromatin and upregulated the loading of minichromosome maintenance complex proteins (MCMs) in a CDC6 dependent manner and promoted DNA repair in a RAD51- and C17orf53-dependent manner. Targeting the ATR-CHK1-RAD51 pathway with ATR inhibitor (ceralasertib), CHK1 inhibitor (rabusertib), or RAD51 inhibitor (B02) significantly decreased the viability of LMW-E-overexpressing hMECs and breast cancer cells. Collectively, our findings delineate a novel role for LMW-E in tumorigenesis mediated by replication stress tolerance and genomic instability, providing novel therapeutic strategies for LMW-E-overexpressing breast cancers.
科研通智能强力驱动
Strongly Powered by AbleSci AI